Loading clinical trials...
Loading clinical trials...
Many normal tissues, including the eyes, brain, and spinal cord are very close to cancers in the nasopharynx. The dose of radiation delivered to the cancer is limited by tolerance of these normal tiss...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Health Network, Toronto
Collaborators
NCT07326358 · Nasopharyngeal Neoplasms, Laryngeal Disease
NCT07277764 · Nasopharyngeal Carcinoma (NPC), Recurrent Nasopharyngeal Neoplasms
NCT06811844 · Nasopharyngeal Neoplasms, PD-1 Inhibitor, and more
NCT05807880 · Nasopharyngeal Neoplasms
NCT02611960 · Nasopharyngeal Neoplasms
Princess Margaret Hospital
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions